Authors:
Oyibo, SO
Jude, EB
Tarawneh, I
Nguyen, HC
Armstrong, DG
Harkless, LB
Boulton, AJM
Citation: So. Oyibo et al., The effects of ulcer size and site, patient's age, sex and type and duration of diabetes on the outcome of diabetic foot ulcers, DIABET MED, 18(2), 2001, pp. 133-138
Authors:
Jude, EB
Oyibo, SO
Chalmers, N
Boulton, AJM
Citation: Eb. Jude et al., Peripheral arterial disease in diabetic and nondiabetic patients - A comparison of severity and outcome, DIABET CARE, 24(8), 2001, pp. 1433-1437
Authors:
Oyibo, SO
Jude, EB
Tarawneh, I
Nguyen, HC
Harkless, LB
Boulton, AJM
Citation: So. Oyibo et al., A comparison of two diabetic foot ulcer classification systems - The Wagner and the University of Texas wound classification systems, DIABET CARE, 24(1), 2001, pp. 84-88
Authors:
Jude, EB
Selby, PL
Burgess, J
Lilleystone, P
Mawer, EB
Page, SR
Donohoe, M
Foster, AVM
Edmonds, ME
Boulton, AJM
Citation: Eb. Jude et al., Bisphosphonates in the treatment of Charcot neuroarthropathy: a double-blind randomised controlled trial, DIABETOLOG, 44(11), 2001, pp. 2032-2037
Authors:
Abd-El-Aleem, SA
Ferguson, MWJ
Appleton, I
Kairsingh, S
Jude, EB
Jones, K
McCollum, CN
Ireland, GW
Citation: Sa. Abd-el-aleem et al., Expression of nitric oxide synthase isoforms and arginase in normal human skin and chronic venous leg ulcers, J PATHOLOGY, 191(4), 2000, pp. 434-442
Authors:
Bakytny, R
Jude, EB
Gibson, JM
Boulton, AJM
Ferguson, MWJ
Citation: R. Bakytny et al., Lack of insulin-like growth factor I (IGF I) in the basal keratinocyte layer of diabetic skin and diabetic foot ulcers, J PATHOLOGY, 190(5), 2000, pp. 589-594
Authors:
Tentolouris, N
Jude, EB
Smirnof, I
Knowles, EA
Boulton, AJM
Citation: N. Tentolouris et al., Methicillin-resistant Staphylococcus aureus: an increasing problem in a diabetic foot clinic, DIABET MED, 16(9), 1999, pp. 767-771
Authors:
Jude, EB
Boulton, AJM
Ferguson, MWJ
Appleton, I
Citation: Eb. Jude et al., The role of nitric oxide synthase isoforms and arginase in the pathogenesis of diabetic foot ulcers: possible modulatory effects by transforming growth factor beta 1, DIABETOLOG, 42(6), 1999, pp. 748-757